Pancreatic Cancer Research

ResearcherJilin UniversityActive in the last 2 years

Yuanda Liu

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-5095-8466; OpenAlex author ID A5006815385. Sources: OpenAlex.

Their work

Papers
2 (first author 1, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
8
Papers, trials and grants by year

2022: 1 paper · 2023: none · 2024: none · 2025: 1 paper

Papers 2

  1. AGER-dependent macropinocytosis drives resistance to KRAS-G12D-targeted therapy in advanced pancreatic cancer. First author DOI 10.1126/scitranslmed.adp4986↗
  2. The role of metabolic reprogramming in pancreatic cancer chemoresistance. Last author DOI 10.3389/fphar.2022.1108776↗

Closest collaborators

The 8 strongest of 8 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Chang Liu · 1 shared paper, 2022 · strength 0.26
  2. Changfeng Li · 1 shared paper, 2025 · strength 0.25
  3. Jiao Liu · 1 shared paper, 2025 · strength 0.25
  4. Yangchun Xie · 1 shared paper, 2025 · strength 0.25
  5. Fangquan Chen · 1 shared paper, 2025 · strength 0.25
  6. Herbert J. Zeh · 1 shared paper, 2025 · strength 0.25
  7. Rui Kang · 1 shared paper, 2025 · strength 0.25
  8. Daolin Tang · 1 shared paper, 2025 · strength 0.25

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.